elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26865490-A487E22D-5732-45E5-8796-32C3E233E600
Q26865490-A487E22D-5732-45E5-8796-32C3E233E600
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26865490-A487E22D-5732-45E5-8796-32C3E233E600
Systemic and targeted therapies for early-stage lung cancer
P2860
Q26865490-A487E22D-5732-45E5-8796-32C3E233E600
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26865490-A487E22D-5732-45E5-8796-32C3E233E600
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc3d0dcf70661be2d88d697102740060ee695fb3
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer